Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Blinded, randomized study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ measles-mumps-rubella-varicella candidate vaccine given to healthy children during the second year of life
Combined Measles, Mumps, Rubella, Varicella Vaccine
103388
NCT00127010
Measles; Mumps; Rubella; Varicella
Phase 3
 
A follow on study 104690 was conducted. An annotated case report form is not available for this study. A blank case report form will be provided.
October 2014

Powered by ideaPoint, Inc.